ILLUMINA, INC. · Laboratory Analytical Instruments

ILMN

Low riskNext report: In 2 days (est.)

View price ↗

The short version

A profitable company with steady sales.

Going well

Profitable, keeps 20% of sales as profit
Brings in more cash than it spends
High return on equity: 33%

Money moves

No insider buying or selling in the last 30 days
Institutions added 0.2% to their holdings in the quarter ending June 2026 (449 bought, 390 sold)
Held by Ray Dalio (Bridgewater), Cathie Wood (ARK Invest)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$270.88+0.6% that day

Company value: $40.9B; Share price times all shares
Price vs profit (P/E): 50.5x; You pay about $51 for each $1 of yearly profit
Price vs sales: 9.1x; Company value is 9.1 times a year of sales
Cash vs value: 3%; Cash as a share of company value
Debt vs value: 4%; Debt as a share of company value

From ILMN's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$1.2B+9.4% vs a year earlier

Oct '23Tap a barJun '26

Last 12 months: $4.5B, up 4.9% from the 12 months before. Over 5 years, sales grew about 6.0% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of ILMN. Starting points are the company's recent numbers.

Sales growth+5% a yearRecently: +4.9% a yearProfit margin18%Last 12 months: 18.4%P/E at the end40xToday: 50.5x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$5.7B

Profit in 5 years$1.0B

Price these guesses point to$273.43+0.9% vs $270.88 todayAbout +0.2% a year, before dividends

What today's price needs: with a 18% margin and a 40x P/E, sales would have to grow about 4.8% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

5/7Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.33.4%
MissDebt under half of equityNot relying on borrowed money.0.55x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.19.6%
MissProfitable every yearSteady profits, not one good year.7 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$931.0M
PassShare count not growingNot diluting owners. Falling means buybacks.-0.6% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.66.1%

Revenue: $4.3B; -0.7% vs prior year
5-year growth: +6.0%/yr; revenue, per year
Total debt: $1.5B; 0.55x equity
Current ratio: 2.08x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.